Company*
(Country;
Symbol)

Company* (Country)

Type/Product Area

Terms/Details (Date)


Agilent
Technologies

Inc.
(NYSE:A)

IBM Corp.

Agreement to develop an informatics system designed to aid in drug discovery and development

The companies will collaborate to make IBM's DiscoveryLink data integration technology compatible with Agilent's Synapsia informatics Workbench software family (8/21)

AxCell Bio-
sciences
(subsidiary
of Cytogen Corp.; CYTO)

IBM Corp.

Agreement in which AxCell is using the DB2 database technology of IBM to help chart communication pathways within cells that enable proteins to interact and cause or prevent diseases

AxCell also will augment its internal data mining system with IBM DiscoveryLink data integration software (8/16)

Incyte Genomics
Inc.
(INCY)

TimeLogic
Corp.

Agreement to integrate TimeLogic's bioinformatics system, DeCypher, into Incyte's LifeSeq Foundation information product

Financial terms were not disclosed (8/22)

Genomatica
Inc.*

The Dow
Chemical
Co.

Research agreement to use Genomatica's SimPheny modeling platform to develop an in silico metabolic model for Dow's use in microbial metabolism and bioprocess modeling

Financial terms were not disclosed but include research support and milestone payments (9/18)

PNP
Therapeutics

Inc.*

Mayne Group
(Australia)

Exclusive agreement to license its patented cell-killing gene technology that is a component in Mayne's prostate cancer treatment, FP253

Mayne will combine PNP's technology with other technology licensed from an Australian research organization (8/23)

Qiagen NV
(the Netherlands; QGENF)

Precision
Systems
Science Co.
Ltd. (Japan)

Agreement to purchase certain automation components for Qiagen's automated nucleic acid, protein and cell purification solutions from Precision Systems Science

Certain components will be available on an exclusive basis (8/16)

Sequenom
Inc.
(SQNM)

Samsung Advanced Institute of Technology

Research agreement for genome-wide screens to identify potential disease-related markers

SAIT plans to use the markers to develop its biochips; Sequenom and SAIT will share commercial rights to disease-gene discoveries and other intellectual property generated in the collaboration (6/18)

Third Wave Technologies
Inc.
(TWTI)

PointOne
Systems
and Aurora HealthCare

Collaboration on an application of genetic medicine for cardiovascular care

The program will use genetic data to develop individualized patient care plans designed to prevent the occurrence or advancement of cardiovascular disease (8/6)

TurboGenomics
Inc.*

IBM Life
Sciences

Collaboration to combine IBM infrastructure software and TurboGenomics tools for distributing application workloads and managing work flows across computing clusters and grids

TurboGenomics' bioinformatics tools will become components of the IBM Life Sciences Framework (9/4)


Notes:

# This chart does not include agreements that involve agricultural product development.

* Private companies are indicated with an asterisk.

Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.

NYSE = New York Stock Exchange